TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21458810

Group type: COMPARATOR
Intervention: Systemic methotrexate (MTX), n=13
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Chemoembolization with MTX and gelatin sponge (GS), n=15
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Chemoembolization with MTX and polyvinyl alcohol (PVA), n=16
Number of subjects: 44
Study: 18005494

Group type: EXPERIMENTAL
Intervention: Active Cognitive Therapy for Early Psychosis (ACE)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Befriending
Number of subjects: 62
Study: 16096516

Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12393109

Group type: EXPERIMENTAL
Intervention: Postoperative pain scores via visual analog scale (0‐100) in depressed patients
Number of subjects: 60

Group type: COMPARATOR
Intervention: Postoperative pain scores via visual analog scale (0‐100) in control patients
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Current perception thresholds at 5 Hz in depressed patients
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Current perception thresholds at 250 Hz in depressed patients
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Current perception thresholds at 2000 Hz in depressed patients
Number of subjects: 60

Group type: COMPARATOR
Intervention: Current perception thresholds at 5 Hz in control patients
Number of subjects: 60

Group type: COMPARATOR
Intervention: Current perception thresholds at 250 Hz in control patients
Number of subjects: 60

Group type: COMPARATOR
Intervention: Current perception thresholds at 2000 Hz in control patients
Number of subjects: 60
Study: 10025601

Group type: EXPERIMENTAL
Intervention: 25 microg/kg rhDNase
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 125 microg/kg rhDNase
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17

Group type: COMPARATOR
Intervention: All groups (25 microg/kg, 125 microg/kg, and placebo)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: rhDNase
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: IV administration of rhDNase
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: SC administration of rhDNase
Number of subjects: 17
Study: 7582381

Group type: EXPERIMENTAL
Intervention: Triple therapy (azathioprine + prednisolone + CsA)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventional therapy (azathioprine + prednisolone)
Number of subjects: 26
Study: 1702010

Group type: EXPERIMENTAL
Intervention: Radiotherapy and bleomycin with hyperthermia
Number of subjects: 101

Group type: COMPARATOR
Intervention: Radiotherapy and bleomycin
Number of subjects: 101
Study: 380611

Group type: EXPERIMENTAL
Intervention: Ethamsylate (Dicynene)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 31646650

Group type: EXPERIMENTAL
Intervention: Pomegranate juice (PJ)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study: 31099698

Group type: EXPERIMENTAL
Intervention: Usual care plus specialty palliative care (PC)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 30
Study: 28073907

Group type: EXPERIMENTAL
Intervention: Metformin (850 mg once daily for one week followed by 850 mg twice daily for three weeks)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34

Group type: COMPARATOR
Intervention: Metformin vs Placebo
Number of subjects: 34
Study: 25847207

Group type: EXPERIMENTAL
Intervention: AVAPS‐AE (automatic EPAP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: S/T technology (control)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: AVAPS‐AE
Number of subjects: 60
Study: 23143044

Group type: EXPERIMENTAL
Intervention: 0% glucose acetated Ringer's solution (Group I)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 1% glucose acetated Ringer's solution (Group II)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 5% glucose acetated Ringer's solution (Group III)
Number of subjects: 45
Study: 21211641

Group type: EXPERIMENTAL
Intervention: 3 years of specific immunotherapy (IT3)
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: 5 years of specific immunotherapy (IT5)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 239
Study: 19176282

Group type: EXPERIMENTAL
Intervention: Mediterranean diet adherence (MedDiet)
Number of subjects: 808

Group type: EXPERIMENTAL
Intervention: Components of the Mediterranean diet (olive oil, legumes, red wine)
Number of subjects: 808
Study: 16530721

Group type: COMPARATOR
Intervention: Backboard footstrap
Number of subjects: 22

Group type: COMPARATOR
Intervention: Change in handle configuration on the stairchair
Number of subjects: 22

Group type: COMPARATOR
Intervention: Backboard wheeler
Number of subjects: 22

Group type: COMPARATOR
Intervention: Descent control system (DCS)
Number of subjects: 22
Study: 14976386

Group type: EXPERIMENTAL
Intervention: Dithranol in bio-wash-oil
Number of subjects: 64

Group type: COMPARATOR
Intervention: Micanol cream
Number of subjects: 64

Group type: COMPARATOR
Intervention: Micanol cream in bio-wash-oil
Number of subjects: 64
Study: 11803348

Group type: EXPERIMENTAL
Intervention: rabbit antithymocyte globulin (ATG) 1.25 mg/kg on alternate days, starting at a median interval of 11 days after BMT
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (historical unrelated donor transplants)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: rabbit antithymocyte globulin (ATG)
Number of subjects: 18
Study: 9544598

Group type: EXPERIMENTAL
Intervention: Home care
Number of subjects: 63

Group type: COMPARATOR
Intervention: Traditional inpatient care
Number of subjects: 63
Study: 9422123

Group type: EXPERIMENTAL
Intervention: VIP (solvent/detergent virus-inactivated plasma)
Number of subjects: 14

Group type: COMPARATOR
Intervention: FFP (fresh frozen plasma)
Number of subjects: 14
Study: 3183937

Group type: EXPERIMENTAL
Intervention: 10-0 nylon
Number of subjects: 85

Group type: COMPARATOR
Intervention: 9-0 nylon
Number of subjects: 85

Group type: COMPARATOR
Intervention: 10-0 polyester
Number of subjects: 85
Study: 29573659

Group type: EXPERIMENTAL
Intervention: Polygenic risk score (PRS) derived from a conduct disorder genome wide association study
Number of subjects: 561
Study: 28318748

Group type: EXPERIMENTAL
Intervention: Tablet distraction provided by a child life specialist
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 30
Study: 26214775

Group type: EXPERIMENTAL
Intervention: Systemic application of SEC
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Local application of lymphocytes activated by SEC
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 92
Study: 23951950

Group type: EXPERIMENTAL
Intervention: Numerical anchors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vague quantifiers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Specific associations between quantifiers
Number of subjects: 0
Study: 21164121

Group type: EXPERIMENTAL
Intervention: 1-Hz repetitive transcranial magnetic stimulation over the right-hemispheric inferior frontal gyrus
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (vertex stimulation)
Number of subjects: 0
Study: 18791411

Group type: EXPERIMENTAL
Intervention: Gd‐BOPTA (0.1 mmol/kg bodyweight)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Gd‐DTPA (0.1 mmol/kg bodyweight)
Number of subjects: 12
Study: 15115901

Group type: EXPERIMENTAL
Intervention: 2 mg oral oestradiol for 3 months
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 18
Study: 11430611

Group type: EXPERIMENTAL
Intervention: Gentle teaching
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Behaviour modification
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 77
Study: 9704766

Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasonography (with sonohysterography if endometrial thickness was >4 mm)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Office hysteroscopy
Number of subjects: 53
Study: 7989942

Group type: EXPERIMENTAL
Intervention: rhGM-CSF at 5, 10, or 20 micrograms/kg, administered subcutaneously (SC) on days 4 to 13 of each cycle
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: rhGM-CSF at 5, 10, or 20 micrograms/kg
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: 10 micrograms/kg of rhGM-CSF
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: rhGM-CSF
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: 10 and 20 micrograms/kg rhGM-CSF
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: 5 micrograms/kg rhGM-CSF
Number of subjects: 290
Study: 3185315

Group type: EXPERIMENTAL
Intervention: Automated blood pressure monitor
Number of subjects: 132

Group type: COMPARATOR
Intervention: Standard mercury manometer
Number of subjects: 132
Study: 29119246

Group type: EXPERIMENTAL
Intervention: Speed Endurance Training (SET)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Small-Sided Game Training (SSG)
Number of subjects: 39
Study: 27130911

Group type: EXPERIMENTAL
Intervention: Untreated celiac disease (CD)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Self-reported NCGS
Number of subjects: 45

Group type: COMPARATOR
Intervention: Treated celiac disease (CD)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 45
Study: 23983096

Group type: EXPERIMENTAL
Intervention: Immediate intervention group (N=94)
Number of subjects: 386

Group type: COMPARATOR
Intervention: Delayed intervention group (N=96)
Number of subjects: 386

Group type: COMPARATOR
Intervention: Observational group (N=196)
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: Intervention group (N=190)
Number of subjects: 386
Study: 22879441

Group type: EXPERIMENTAL
Intervention: Protocolized rehabilitation program that commenced in the ICU and continued for 8 weeks post-discharge as an outpatient program.
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Outpatient classes following the rehabilitation program.
Number of subjects: 74

Group type: COMPARATOR
Intervention: Standard care (local standard care).
Number of subjects: 74
Study: 20881947

Group type: EXPERIMENTAL
Intervention: Sustained release d-amphetamine (SR-AMP) 0, 30, and 60 mg/day
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sustained release d-amphetamine (SR-AMP)
Number of subjects: 8
Study: 18591600

Group type: EXPERIMENTAL
Intervention: Herbert screw fixation
Number of subjects: 71

Group type: COMPARATOR
Intervention: Below-elbow plaster cast immobilisation
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 71
Study: 15899030

Group type: EXPERIMENTAL
Intervention: Infliximab therapy (discontinued after 3 years)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Retreatment with infliximab
Number of subjects: 42
Study: 11756596

Group type: COMPARATOR
Intervention: Interferon beta-1b (Betaferon)
Number of subjects: 718

Group type: EXPERIMENTAL
Intervention: Annual MRI outcomes
Number of subjects: 718

Group type: EXPERIMENTAL
Intervention: Cumulative number of active T2 lesions
Number of subjects: 718

Group type: EXPERIMENTAL
Intervention: Monthly imaging in a subgroup of 125 patients
Number of subjects: 718
Study: 9653638

Group type: EXPERIMENTAL
Intervention: Coping-oriented group therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unstructured supportive group therapy
Number of subjects: 0
Study: 7925148

Group type: EXPERIMENTAL
Intervention: Gabapentin (GBP)
Number of subjects: 23
Study: 3246215

Group type: EXPERIMENTAL
Intervention: Clocapramine
Number of subjects: 52

Group type: COMPARATOR
Intervention: Sulpiride
Number of subjects: 52
Study: 31721398

Group type: EXPERIMENTAL
Intervention: Oxycodone
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Oxycodone + Naloxegol
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49

Group type: COMPARATOR
Intervention: Oxycodone + Placebo
Number of subjects: 49
Study: 31323005

Group type: EXPERIMENTAL
Intervention: Aerobic training (3 days/week, 20-75 min per day at 45-75% maximum heart rate for 12 weeks)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Medicine + training (GnRHa once a month, 1 mL every 4 weeks by intramuscular injection + aerobic training)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Detraining (4 weeks after the last training session)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Medication group (GnRHa only)
Number of subjects: 45
Study: 27743396

Group type: EXPERIMENTAL
Intervention: Subcrestal implants placed 2 mm below the alveolar crest
Number of subjects: 23

Group type: COMPARATOR
Intervention: Crestal implants placed at bone level
Number of subjects: 23
Study: 26630435

Group type: EXPERIMENTAL
Intervention: activL TDR
Number of subjects: 324
Study: 23700728

Group type: EXPERIMENTAL
Intervention: Modified Devine's operation (treatment group)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Circumcision (control group)
Number of subjects: 20
Study: 21292200

Group type: EXPERIMENTAL
Intervention: BIS-guided sevoflurane anesthesia
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: AAI-guided sevoflurane anesthesia
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard practice group (clinical parameters only)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: BIS-guided anesthesia
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: AAI-guided anesthesia
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard practice group
Number of subjects: 160
Study: 19757982

Group type: EXPERIMENTAL
Intervention: Herbal combination therapy (Hypericum perforatum and Vitex agnus-castus)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 17078279

Group type: COMPARATOR
Intervention: 2-layer technique (Group B)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: microlayer technique (Group C)
Number of subjects: 40
Study: 14765699

Group type: EXPERIMENTAL
Intervention: Sliding mode closed-loop FES controller
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open-loop controlled FES devices
Number of subjects: 0
Study: 11769822

Group type: EXPERIMENTAL
Intervention: Kava
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 9174317

Group type: EXPERIMENTAL
Intervention: Lidocaine (0.1 mL intradermal injection of 0.5%)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Lidocaine plus Morphine (0.1 mL of 0.5 mg of morphine plus lidocaine 1%)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Reference site (no injection)
Number of subjects: 10
Study: 8196158

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate haemodialysis/filtration
Number of subjects: 8

Group type: COMPARATOR
Intervention: Acetate haemodialysis/filtration
Number of subjects: 8
Study: 31664909

Group type: EXPERIMENTAL
Intervention: Hypertension (HTN) prevalence
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Age 45 and older
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Obesity
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Overweightness
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Waist circumference > 102 cm in men and > 88 cm in women
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Light occupational physical activity
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Walking or riding a bicycle for < 5 days/week
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Lack of sport activity
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Khat use
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Household size of two
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Household size of three or more
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Family history of HTN
Number of subjects: 312
Study: 29394511

Group type: EXPERIMENTAL
Intervention: Exposure and Response Prevention (EX/RP)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 27059387

Group type: EXPERIMENTAL
Intervention: Protocol I (100 ml of 350 mg iodine/ml iodinated CM; n=16)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Protocol II (50 ml of 350 mg iodine/ml iodinated CM; n=17)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Protocol I and II
Number of subjects: 33
Study: 24670467

Group type: EXPERIMENTAL
Intervention: Drained blood reinfusion (group A)
Number of subjects: 98

Group type: COMPARATOR
Intervention: No drained blood reinfusion (group B)
Number of subjects: 98
Study: 23148715

Group type: EXPERIMENTAL
Intervention: Mixed (group-individual) modality intervention incorporating Motivational Interviewing, Dialectical Behavior Therapy skills, and job-related skills.
Number of subjects: 174

Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 174
Study: 21068707

Group type: EXPERIMENTAL
Intervention: Manual hyperinflation (MH)
Number of subjects: 74
Study: 18054379

Group type: EXPERIMENTAL
Intervention: Semantics decision task with early delivery of the go signal
Number of subjects: 0

Group type: COMPARATOR
Intervention: Semantics decision task with delayed delivery of the go signal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lexical decision task with early delivery of the go signal
Number of subjects: 0
Study: 16545641

Group type: EXPERIMENTAL
Intervention: Albuterol (5 microg/min)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate (5 microg/min)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: CIMT measurement
Number of subjects: 81
Study: 12861468

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol adjustable dosing (n = 69)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Budesonide/formoterol fixed dosing (n = 58)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol adjustable dosing
Number of subjects: 127

Group type: COMPARATOR
Intervention: Budesonide/formoterol fixed dosing
Number of subjects: 127
Study: 10733048

Group type: EXPERIMENTAL
Intervention: Prevalent vertebral deformities
Number of subjects: 6459
Study: 8801736

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (irradiation of the remaining breast tissue)
Number of subjects: 278

Group type: COMPARATOR
Intervention: Control group (no postoperative radiotherapy)
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 278
Study: 1281081

Group type: EXPERIMENTAL
Intervention: Quantified EEG frequency analysis (EEGFA)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Conventional EEG
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: EEGFA
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: EEGFA and Conventional EEG
Number of subjects: 25
Study: 6715084

Group type: EXPERIMENTAL
Intervention: 2% solution of lignocaine iontophoresed for 10 min at 1‐2.5 mA
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo iontophoresis
Number of subjects: 0
Study: 31216875

Group type: EXPERIMENTAL
Intervention: GCSWLI
Number of subjects: 50

Group type: COMPARATOR
Intervention: WLC
Number of subjects: 50
Study: 29956503

Group type: EXPERIMENTAL
Intervention: Habit formation-enhanced group-based DPP
Number of subjects: 208

Group type: COMPARATOR
Intervention: Standard group-based DPP
Number of subjects: 208
Study: 27097959

Group type: EXPERIMENTAL
Intervention: Tirofiban
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control
Number of subjects: 107
Study: 25138574

Group type: EXPERIMENTAL
Intervention: Metformin 1,000 mg daily
Number of subjects: 84

Group type: COMPARATOR
Intervention: Pioglitazone 30 mg daily
Number of subjects: 84
Study: 22142309

Group type: COMPARATOR
Intervention: PKEK treatment
Number of subjects: 76

Group type: COMPARATOR
Intervention: PKEK combined with sodium ascorbyl phosphate (SAP)
Number of subjects: 76

Group type: COMPARATOR
Intervention: PKEK added to SAP-containing preparation
Number of subjects: 76

Group type: COMPARATOR
Intervention: PKEK+SAP formulation
Number of subjects: 76
Study: 20684789

Group type: EXPERIMENTAL
Intervention: Physical exercise intervention
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: Combined physical activity and counseling
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: Studies defining a step goal
Number of subjects: 660
Study: 17979862

Group type: EXPERIMENTAL
Intervention: Higher-intensity-individualized (HI) training group
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lower-intensity-generalized (LG) training group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (C) group (no treadmill training)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All groups (HI, LG, C)
Number of subjects: 30
Study: 15731535

Group type: COMPARATOR
Intervention: Myocardial perfusion alone
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Combined wall motion analysis with myocardial perfusion
Number of subjects: 143
Study: 12196649

Group type: EXPERIMENTAL
Intervention: Active transcranial magnetic stimulation (TMS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham stimulation (placebo)
Number of subjects: 24
Study: 9825232

Group type: EXPERIMENTAL
Intervention: Sumatriptan (group A)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo (group B)
Number of subjects: 41
Study: 7666093

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus AS101
Number of subjects: 44

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 44
Study: 2495983

Group type: EXPERIMENTAL
Intervention: Almitrine bismesylate 50 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Almitrine bismesylate 100 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Almitrine bismesylate 150 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 919799

Group type: EXPERIMENTAL
Intervention: Intramuscular Arteparon forte injections and physical therapy (group 1)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Physical therapy only (group 2)
Number of subjects: 115
Study: 31511399

Group type: EXPERIMENTAL
Intervention: Water treadmill (WT) conditioning for 18 days
Number of subjects: 9

Group type: COMPARATOR
Intervention: Dry treadmill (DT) control
Number of subjects: 9
Study: 31025878

Group type: EXPERIMENTAL
Intervention: Insulin patch
Number of subjects: 278

Group type: COMPARATOR
Intervention: Insulin pen
Number of subjects: 278